1 Maintaining levels of this neurotransmitter is critical for a healthy brain
Continued engagement with addiction specialists, behavioral interventions, and FDA-approved medications for substance use disorders remains the standard of care
Conclusion Emerging evidence underscores the cardioprotective effects of GLP-1RAs, which make them potentially useful for different subpopulations of patients with cardiovascular diseases, including those with HFpEF
Especially, we thank Atsuhito Tone, Hideo Machimura, Hidetoshi Shimura, Hiroshi Takeda, Hisashi Yokomizo, Kei Takeshita, Keiichi Chin, Masaaki Miyauchi, Masuo Saburi, Miwa Ohta, Miwako Yomota, Moritsugu Kimura, Nobuo Hatori, Shinichi Nakajima, Shun Ito, Takashi Murata, Takayuki Furuki, Takuya Hashimoto, Tomoya Umezono, Yuki Senda, and Yuichi Takashi, who contributed the RECAP study